danish pharmaceutical company Novo Nordisk has launched its obesity treatment Wegovy pill (oral) in the U.S. The product is available on a self-pay basis, with prices ranging from $149 to $299 per month, depending on the dose.
wigovy pill prices
- 1.5 mg (starter dose): $149 per month
- 4 mg: $149 per month (until April 15, 2026), then increases to $199 per month
- 9 mg: $299 per month
- 25 mg (maintenance-high dose): $299 per month
Connection to TrumpRx
the Trump administration has announced a policy of lowering the price of GLP-1 class obesity drugs through TrumpRx, and has stated that if future oral (pill) forms of GLP-1 receive FDA approval, the initial dose will be priced at around $150. Some reports have also suggested that the starter dose of the HugoBee pill will be accessible on TrumpRx for $149 per month.
more competition
according to media reports, Novo Nordisk’s launch of the Wigobi pill signals the beginning of the end for the oral obesity treatment market. at the same time, competitor Eli Lilly is also developing its own oral obesity drug, so the price and accessibility competition is likely to intensify.
🔻함께보면 즐거운 콘텐츠 모음🔻
fall Mattress Care: 5 Steps to a Better Night’s Sleep
design icons reborn: the return of timeless masters
How to survive in the age of AI: A complete analysis of the top 10 keywords in ‘Trend Korea 2026’
iKEA X Gustav Vestmann limited edition collection premieres in South Korea
your Home Is the Best Gym! 7 Home Workout Items to Inspire Your Workout Desire
designer Seungji Moon’s first furniture brand ‘Habagooden’ visits Hannam-dong showroom
fritz Hansen Repair Pop-Up, Series 7 Celebrates 70 Years of Sustainable Choices
fritz Hansen Repair Pop-Up, Series 7 Celebrates 70 Years of Sustainable Choices
eat and drink in style: 11 of the newest dining and café openings from fashion brands
the world of buccellati just got bigger and deeper
house of New Worlds permeates department stores
eat and drink in style: 11 of the newest dining and cafe openings from fashion brands
📝 리뷰 작성하기